Industry | Venture capital |
---|---|
Founded | 2007 |
Headquarters | Boston, Massachusetts, United States |
Key people | Mark J. Levin Kevin P. Starr Robert I. Tepper |
Website | thirdrockventures |
Third Rock Ventures is a venture capital firm with offices in Boston and San Francisco. Founded in 2007, the firm invests in biotechnology startups.
Funding and investments
This section contains promotional content. Please help improve it by removing promotional language and inappropriate external links, and by adding encyclopedic text written from a neutral point of view. (April 2020) (Learn how and when to remove this message) |
Third Rock Ventures has raised $3.8 billion since it was created and invested in more than 60 companies, including Sage Therapeutics, Editas Medicine, Constellation Pharmaceuticals and Flare Therapeutics.
References
- DeAngelis, Allison. "Third Rock Ventures plots next chapter after raising $1.1 billion fund". STAT. Retrieved 16 April 2024.
- Timmeran, Luke (31 October 2016). "Third Rock Ventures, One of Biotech's Daring Investors, Raises $616M For More Startups". Forbes. Retrieved 22 August 2018.
- Terry, Mark. "In Tough Biotech Market, Third Rock Raises New $1.1B Fund". BioSpace. Retrieved 16 April 2024.
- DeAngelis, Allison. "Third Rock Ventures plots next chapter after raising $1.1 billion fund". STAT. Retrieved 16 April 2024.
This United States corporation or company article is a stub. You can help Misplaced Pages by expanding it. |